SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-002475
Filing Date
2020-02-12
Accepted
2020-02-12 16:53:46
Documents
53
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20191231_10q.htm 10-Q 964409
2 EXHIBIT 31.1 CERTIFICATON OF CO-CHIEF EXECUTIVE OFFICERS ex_171642.htm EX-31.1 15018
3 EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex_171643.htm EX-31.2 15380
4 EXHIBIT 32.1 CO-CEOS CERTIFICATION OF PERIODIC REPORT ex_171644.htm EX-32.1 6350
5 EXHIBIT 32.2 CFO CERTIFICATION OF PERIODIC REPORT ex_171645.htm EX-32.2 5022
  Complete submission text file 0001437749-20-002475.txt   4843659

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20191231.xml EX-101.INS 1160574
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20191231.xsd EX-101.SCH 46773
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20191231_cal.xml EX-101.CAL 43927
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20191231_def.xml EX-101.DEF 288587
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20191231_lab.xml EX-101.LAB 258665
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20191231_pre.xml EX-101.PRE 307325
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 20605010
SIC: 2834 Pharmaceutical Preparations